MARC details
| 000 -LEADER |
|---|
| fixed length control field |
10698namaa22004451i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - أخر تعامل مع التسجيلة |
|---|
| control field |
20251023114533.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
251014s2025 ua a|||frm||| 000 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloguing agency |
EG-GICUC |
| Language of cataloging |
eng |
| Transcribing agency |
EG-GICUC |
| Modifying agency |
EG-GICUC |
| Description conventions |
rda |
| 041 0# - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| Language code of summary or abstract |
eng |
| -- |
ara |
| 049 ## - Acquisition Source |
|---|
| Acquisition Source |
Deposit |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.01 |
| 092 ## - LOCALLY ASSIGNED DEWEY CALL NUMBER (OCLC) |
|---|
| Classification number |
616.01 |
| Edition number |
21 |
| 097 ## - Degree |
|---|
| Degree |
M.Sc |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
|---|
| Local Call Number |
Cai01.08.06.M.Sc.2025.Am.M |
| 100 0# - MAIN ENTRY--PERSONAL NAME |
|---|
| Authority record control number or standard number |
Amr Elsayed Ibrahim Ahmed Elghopashy, |
| Preparation |
preparation. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Molecular study on carbapenem resistant klebsiella pneumoniae isolated from egyptian hospitals / |
| Statement of responsibility, etc. |
Amr Elsayed Ibrahim Ahmed Elghopashy ; Supervision Prof. Dr. Yasser El Mohammady Ragab, Prof. Dr. Aymen Samir Yassin, Prof. Dr. Mohamed Abd El-Gawad El-Sayed Ahmed. |
| 246 15 - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
دراﺳﺔ ﺟﺰﯾﺌﯿﺔ ﻋﻦ اﻟﻜﻠﺒﺴﯿﻠﮫ اﻟﺮﺋﻮﯾﺔ اﻟﻤﻘﺎوﻣﺔ ﻟﻠﻜﺎرﺑﺎﺑﯿﻨﯿﻤﺎت واﻟﻤﻌﺰوﻟﺔ ﻣﻦ اﻟﻤﺴﺘﺸﻔﯿﺎت اﻟﻤﺼﺮﯾﺔ |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Date of production, publication, distribution, manufacture, or copyright notice |
2025. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
146 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
25 cm. + |
| Accompanying material |
CD. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rda content |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
Unmediated |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Source |
rdacarrier |
| 502 ## - DISSERTATION NOTE |
|---|
| Dissertation note |
Thesis (M.Sc)-Cairo University, 2025. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Bibliography: pages 119-146. |
| 520 #3 - SUMMARY, ETC. |
|---|
| Summary, etc. |
Carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections are considered a global critical concern, causing a serious threat to public health. CR-KP strains have been widely disseminated worldwide in recent years, affecting countries with varying income levels, including low-, middle-, and upper-income countries. The incidence of CR-KP infections is tremendously increasing in developing countries, such as Egypt, posing a significant threat to public health.<br/>Ninety-four clinically significant K. pneumoniae isolates were collected from two tertiary care Egyptian hospitals: Al-Kasr Al-Ainy hospital, Cairo, Egypt and Memorial Souad Kafafi University hospital, Giza, Egypt over one year. All collected isolates were subcultured, and their identification as K. pneumoniae ssp. pneumoniae was confirmed via the automated VITEK® 2 system and the MALDI-TOF MS. Antimicrobial susceptibility testing (AST) of all tested K. pneumoniae isolates was examined using the Kirby-Bauer disk diffusion method and MICs were determined by the automated VITEK® 2 system, then confirmed for imipenem, meropenem, and colistin via the routine broth microdilution method. Subsequently, phenotypic detection of carbapenemases, as well as genotypic detection of major carbapenemase-encoding genes were carried out.<br/>Based on the automated VITEK® 2 system's AST results, all clinical K. pneumoniae isolates were multidrug-resistant (MDR). The highest detected resistance patterns were toward β- lactam antibiotics, followed by quinolones and aminoglycosides, where the prevalence of carbapenems resistance was too high, with 94.68% of isolates being resistant to imipenem with MICs >16 µg/ml. Phenotypic assays showed that 98.9% of CR-KP isolates produced carbapenemase(s), while PCR technique revealed that 97.9% of tested isolates harbored at least one carbapenemase-encoding gene. BlastN analysis of the sequenced PCR products against GenBank's non-redundant genome sequences showed that the blaOXA-48 gene was the most predominant carbapenemase-encoding genotype among our isolates, found in 89/94 of the tested isolates (94.7%), followed by blaNDM-1 (65/94, 69.1%) and blaKPC-2 (5/94, 5.3%). Additionally, the co-existence of both blaOXA-48 and blaNDM-1 carbapenemase genes in certain isolates (67%) was also observed.<br/>The high prevalence of carbapenem resistance and the terrifying spread of their encoding genes among K. pneumoniae isolates in Egypt are alarming, leading to limitations in the available<br/>therapeutic options for the management of these serious infections. Carbapenemases of the blaOXA-<br/>48 and blaNDM-1 genotypes are widespread in Egyptian healthcare settings, causing the current increase in carbapenem-resistant bacteria. |
| 520 #3 - SUMMARY, ETC. |
|---|
| Summary, etc. |
ﺗﻌﺘﺒﺮ ﻋﺪوى اﻟﻜﻠﺒﺴﯿﻠﮫ اﻟﺮﺋﻮﯾﺔ اﻟﻤﻘﺎوﻣﺔ ﻟﻠﻜﺎرﺑﺎﺑﯿﻨﯿﻤﺎت ﻣﺼﺪر ﻗﻠﻖ ﻋﺎﻟﻤﻲ ﺑﺎﻟﻎ ﯾﮭﺪد اﻟﺼﺤﺔ اﻟﻌﺎﻣﺔ ﺑﺸﻜﻞ ﺧﻄﯿﺮ. وﻗﺪ اﻧﺘﺸﺮت ھﺬه اﻟﺴﻼﻻت ﻣﻦ اﻟﻜﻠﺒﺴﯿﻠﮫ اﻟﺮﺋﻮﯾﺔ اﻟﻤﻘﺎوﻣﺔ ﻟﻠﻜﺎرﺑﺎﺑﯿﻨﯿﻤﺎت ﺑﺸﻜﻞ واﺳﻊ ﻓﻲ ﺟﻤﯿﻊ أﻧﺤﺎء اﻟﻌﺎﻟﻢ ﻓﻲ اﻟﺴﻨﻮات اﻷﺧﯿﺮة، ﺣﯿﺚ أﺛﺮت ﻋﻠﻰ اﻟﺒﻠﺪان ذات ﻣﺴﺘﻮﯾﺎت اﻟﺪﺧﻞ اﻟﻤﺨﺘﻠﻔﺔ، ﺑﻤﺎ ﻓﻲ ذﻟﻚ اﻟﺒﻠﺪان ذات اﻟﺪﺧﻞ اﻟﻤﻨﺨﻔﺾ واﻟﻤﺘﻮﺳﻂ واﻟﻤﺮﺗﻔﻊ. ﻓﯿﻤﺎ ﺗﺸﮭﺪ اﻟﺒﻠﺪان اﻟﻨﺎﻣﯿﺔ ﻣﺜﻞ ﻣﺼﺮ زﯾﺎدة ھﺎﺋﻠﺔ ﻓﻲ ﻣﻌﺪل اﻧﺘﺸﺎر ﺗﻠﻚ اﻟﻌﺪوى ﻣﻤﺎ ﯾﺸﻜﻞ ﺧﻄﺮًا ﻛﺒﯿﺮًا ﻋﻠﻰ اﻟﺼﺤﺔ اﻟﻌﺎﻣﺔ.<br/>ﺗﻢ ﺟﻤﻊ أرﺑﻌﺔ وﺗﺴﻌﻮن ﻋﯿﻨﺔ ﻣﻦ اﻟﻜﻠﺒﺴﯿﻠﮫ اﻟﺮﺋﻮﯾﺔ ذات اﻷھﻤﯿﺔ اﻟﺴﺮﯾﺮﯾﺔ ﻣﻦ ﻣﺴﺘﺸﻔﯿﯿﻦ ﻣﺼﺮﯾﺘﯿﻦ ﻋﻠﻰ ﻣﺪار ﻋﺎم واﺣﺪ. ﺗﻢ إﻋﺎدة زراﻋﺔ ﺟﻤﯿﻊ اﻟﻌﯿﻨﺎت اﻟﻤﺠﻤﻌﺔ وﺗﻢ ﺗﺄﻛﯿﺪ ﺗﻌﺮﯾﻔﮭﺎ ﻋﻠﻰ أﻧﮭﺎ ﻋﯿﻨﺎت ﻛلبسيله رﺋﻮﯾﺔ ﺑﺎﺳﺘﺨﺪام ﻧﻈﺎم 2 VITEK® اﻵﻟﻲ وﻣﻦ ﺧﻼل MS .MALDI-TOF ﺗﻢ ﻓﺤﺺ ﺣﺴﺎﺳﯿﺔ ﺟﻤﯿﻊ ﻋﺰﻻت اﻟﻜﻠﺒﺴﯿﻠﮫ اﻟﺮﺋﻮﯾﺔ ﺗﺠﺎه اﻟﻤﻀﺎدات اﻟﺤﯿﻮﯾﺔ اﻟﻤﺨﺘﻠﻔﺔ ﺑﺎﺳﺘﺨﺪام طﺮﯾﻘﺔ diffusion disk Kirby-Bauer، وﺗﻢ ﺗﺤﺪﯾﺪ ﺗﺮاﻛﯿﺰ اﻟﺤﺪ اﻷدﻧﻰ اﻟﻤﺜﺒﻂ ﻟﻠﻨﻤﻮ ﻟﻠﻤﻀﺎدات اﻟﻤﯿﻜﺮوﺑﯿﺔ ﺑﺎﺳﺘﺨﺪام ﻧﻈﺎم 2 VITEK® اﻵﻟﻲ، وﺗﻢ ﺗﺄﻛﯿﺪھﺎ ﻟﻺﯾﻤﯿﺒﯿﻨﯿﻢ واﻟﻤﯿﺮوﺑﯿﻨﯿﻢ واﻟﻜﻮﻟﯿﺴﺘﯿﻦ ﺑﻮاﺳﻄﺔ طﺮﯾﻘﺔmicrodilution .broth ﺛﻢ ﺑﻌﺪ ذﻟﻚ ﺗﻢ إﺟﺮاء اﻟﻜﺸﻒ اﻟﻈﺎھﺮي ﻋﻦ إﻧﺘﺎج اﻟﻜﺎرﺑﺎﺑﯿﻨﯿﻤﺎزات وﻛﺬﻟﻚ اﻟﻜﺸﻒ اﻟﺠﯿﻨﻲ ﻟﻠﺠﯿﻨﺎت اﻟﺮﺋﯿﺴﯿﺔ اﻟﻤﻨﺘﺠﮫ ﻟﻠﻜﺎرﺑﺎﺑﯿﻨﯿﻤﺎزات.<br/>اﺳﺘﻨﺎداً إﻟﻰ ﻧﺘﺎﺋﺞ اﺧﺘﺒﺎر اﻟﺤﺴﺎﺳﯿﺔ ﻟﻠﻤﻀﺎدات اﻟﻤﯿﻜﺮوﺑﯿﺔ ﺑﺎﺳﺘﺨﺪام ﻧﻈﺎم 2 VITEK® اﻵﻟﻲ، ﻛﺎﻧﺖ ﺟﻤﯿﻊ ﻋﺰﻻت اﻟﻜﻠﺒﺴﯿﻠﮫ اﻟﺮﺋﻮﯾﺔ اﻟﺴﺮﯾﺮﯾﺔ ﻣﻘﺎوﻣﺔ ﻣﺘﻌﺪدة ﻟﻠﻤﻀﺎدات اﻟﺤﯿﻮﯾﺔ .(MDR) ﻛﺎﻧﺖ أﻧﻤﺎط اﻟﻤﻘﺎوﻣﺔ اﻷﻋﻠﻰ اﻟﻤﻜﺘﺸﻔﺔ ﺗﺠﺎه اﻟﻤﻀﺎدات اﻟﺤﯿﻮﯾﺔ ﻣﻦ ﻧﻮع ﺑﯿﺘﺎ-ﻻﻛﺘﺎم، ﺗﻠﯿﮭﺎ اﻟﻔﻠﻮروﻛﯿﻨﻮﻟﻮﻧﺎت واﻷوﻣﯿﻨﻮﺟﻠﯿﻜﻮﺳﯿﺪات، ﻓﯿﻤﺎ ﻛﺎﻧﺖ ﻧﺴﺒﺔ اﻟﻤﻘﺎوﻣﺔ ﻟﻠﻜﺎرﺑﺎﺑﯿﻨﯿﻤﺎت ﻋﺎﻟﯿﺔ ﻟﻠﻐﺎﯾﺔ، ﺣﯿﺚ ﻛﺎﻧﺖ ٦۸٫۹٤٪ ﻣﻦ اﻟﻌﺰﻻت ﻣﻘﺎوﻣﺔ ﻟﻺﯾﻤﯿﺒﯿﻨﯿﻢ ﻣﻊ ﺣﺪ أدﻧﻰ ﻣﺜﺒﻂ ﻟﻠﻨﻤﻮ أﻛﺒﺮ ﻣﻦ ۱٦ ﻣﯿﻜﺮوﻏﺮام/ﻣﻞ. وأظﮭﺮت اﻟﻔﺤﻮﺻﺎت اﻟﻈﺎھﺮﯾﺔ أن ۹٫۹۸٪ ﻣﻦ ﻋﺰﻻت اﻟﻜﻠﺒﺴﯿﻠﮫ اﻟﺮﺋﻮﯾﺔ اﻟﻤﻘﺎوﻣﺔ ﻟﻠﻜﺎرﺑﺎﺑﯿﻨﯿﻤﺎت ﺗﻨﺘﺞ ﻛﺎرﺑﺎﺑﯿﻨﯿﻤﯿﺰ، ﺑﯿﻨﻤﺎ ﻛﺸﻔﺖ ﺗﻘﻨﯿﺔ ﺗﻔﺎﻋﻞ ﺗﺴﻠﺴﻞ اﻟﺒﻠﻤﺮة أن ۹٫۹۷٪ ﻣﻦ اﻟﻌﺰﻻت اﻟﻤﺨﺘﺒﺮة ﺗﺤﺘﻮي ﻋﻠﻰ ﺟﯿﻦ واﺣﺪ ﻋﻠﻰ اﻷﻗﻞ ﻣﻨﺘﺞ ﻟﻠﻜﺎرﺑﺎﺑﯿﻨﯿﻤﯿﺰ. ﻛﻤﺎ أظﮭﺮ ﺗﺤﻠﯿﻞ BlastN ﻟﻤﻨﺘﺠﺎت ﺗﻔﺎﻋﻞ ﺗﺴﻠﺴﻞ اﻟﺒﻠﻤﺮة اﻟﻤﺘﺴﻠﺴﻠﺔ ﻣﻘﺎﺑﻞ ﺗﺴﻠﺴﻼت اﻟﺠﯿﻨﻮم ﻏﯿﺮ اﻟﻤﺘﻜﺮرة ﻓﻲ ﺑﻨﻚ اﻟﺠﯿﻨﺎت أن ﺟﯿﻦ blaOXA-48 ﻛﺎن اﻟﻨﻤﻂ<br/>اﻟﺠﯿﻨﻲ اﻷﻛﺜﺮ اﻧﺘﺸﺎرًا ﺑﯿﻦ اﻟﻌﺰﻻت ﻟﺪﯾﻨﺎ، ﺣﯿﺚ وﺟﺪ ﻓﻲ ۸۹ ﻣﻦ أﺻﻞ ۹٤ ﻋﯿﻨﺔ ۷)٫۹٤٪(، ﯾﻠﯿﮫ blaNDM-1 ۹٤/٦٥)، ۱٫٦۹٪(<br/>و blaKPC-2 ۹٤/٥)، ۳٫٥٪.( ﺑﺎﻹﺿﺎﻓﺔ إﻟﻰ ذﻟﻚ، ﺗﻢ ﻣﻼﺣﻈﺔ وﺟﻮد ﺟﯿﻨﻲ blaOXA-48 وblaNDM-1 ﻓﻲ ﻋﺰﻻت ﻣﻌﯿﻨﺔ بنسبة<br/>.٪٦۷<br/>إن اﻻرﺗﻔﺎع اﻟﻜﺒﯿﺮ ﻓﻲ ﻣﻘﺎوﻣﺔ اﻟﻜﺎرﺑﺎﺑﯿﻨﯿﻤﺎت واﻻﻧﺘﺸﺎر اﻟﻤﺮوع ﻟﻠﺠﯿﻨﺎت اﻟﻤﻨﺘﺠﺔ ﻟﮭﺎ ﺑﯿﻦ ﻋﺰﻻت اﻟﻜﻠﺒﺴﯿﻠﮫ اﻟﺮﺋﻮﯾﺔ ﻓﻲ ﻣﺼﺮ ﯾﻌﺪ أﻣﺮًا ﻣﺜﯿﺮًا ﻟﻠﻘﻠﻖ، ﻣﻤﺎ ﯾﺆدي إﻟﻰ ﻣﺤﺪودﯾﺔ اﻟﺨﯿﺎرات اﻟﻌﻼﺟﯿﺔ اﻟﻤﺘﺎﺣﺔ ﻟﻠﺘﻌﺎﻣﻞ ﻣﻊ ھﺬه اﻟﻌﺪوى اﻟﺨﻄﯿﺮة. ﺗﻌﺘﺒﺮ ﻛﺎرﺑﺎﺑﯿﻨﯿﻤﯿﺰات ﻣﻦ اﻟﻨﻮع اﻟﺠﯿﻨﻲ blaOXA-48 و blaNDM-1 ﻣﻨﺘﺸﺮة ﺑﺸﻜﻞ واﺳﻊ ﻓﻲ اﻟﺒﯿﺌﺎت اﻟﺼﺤﯿﺔ اﻟﻤﺼﺮﯾﺔ، ﻣﻤﺎ ﯾﺘﺴﺒﺐ ﻓﻲ اﻟﺰﯾﺎدة اﻟﺤﺎﻟﯿﺔ ﻓﻲ اﻟﺒﻜﺘﯿﺮﯾﺎ اﻟﻤﻘﺎوﻣﺔ ﻟﻠﻜﺎرﺑﺎﺑﯿﻨﯿﻤﺎت. |
| 530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE |
|---|
| Issues CD |
Issues also as CD. |
| 546 ## - LANGUAGE NOTE |
|---|
| Text Language |
Text in English and abstract in Arabic & English. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Microbiology |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
الميكوبيولوجيا الطبية |
| 653 #1 - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Carbapenem |
| -- |
resistant Klebsiella pneumoniae (CR-KP) |
| -- |
Carbapenems |
| -- |
MDR |
| -- |
Carbapenemases |
| -- |
blaOXA-48 |
| -- |
blaNDM-1 |
| 700 0# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Yasser El Mohammady Ragab |
| Relator term |
thesis advisor. |
| 700 0# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Aymen Samir Yassin |
| Relator term |
thesis advisor. |
| 700 0# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Mohamed Abd El-Gawad El-Sayed Ahmed |
| Relator term |
thesis advisor. |
| 900 ## - Thesis Information |
|---|
| Grant date |
01-01-2025 |
| Supervisory body |
Yasser El Mohammady Ragab |
| -- |
Aymen Samir Yassin |
| -- |
Mohamed Abd El-Gawad El-Sayed Ahmed |
| Universities |
Cairo University |
| Faculties |
Faculty of Pharmacy |
| Department |
Department of Microbiology and Immunology |
| 905 ## - Cataloger and Reviser Names |
|---|
| Cataloger Name |
Shimaa |
| Reviser Names |
Eman Ghareb |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Thesis |
| Edition |
21 |
| Suppress in OPAC |
No |